Novel Biologics

Serving the needs of many different customers

Charité Research Organisation effectively offers a ‘platform approach’ that allows us to take the core strengths of our concept and service and apply them to the needs of different customers and industries. We believe that every project requires and deserves the same level of medical oversight and scientific excellence. Our commitment and ‘Scientifically Driven’ approach ensure this is true for work on novel compounds, biosimilars or, indeed, products from other industries.

One of the key strengths of Charité Research Organisation is its experience of undertaking First Time in Human, Phase I and Proof of Concept studies with novel biologics. We have undertaken defining studies of new biologics with novel modes of action. Indeed, we have led the way in performing early studies with new classes of biologics, such as dual-binding antibodies.

Company

Scientific Expertise

Operational Excellence

Recruitment

Value

Products

Serving the needs of many different customers

Novel Biologics